Related references
Note: Only part of the references are listed.Cardiac safety profile of rosiglitazone A comprehensive meta-analysis of randomized clinical trials
Edoardo Mannucci et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Ophthalmic lymphoma: epidemiology and pathogenesis
Lene Dissing Sjö
ACTA OPHTHALMOLOGICA (2009)
Electrophilic Peroxisome Proliferator-Activated Receptor-γ Ligands Have Potent Antifibrotic Effects in Human Lung Fibroblasts
Heather E. Ferguson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
microRNA miR-27b impairs human adipocyte differentiation and targets PPARγ
Michael Karbiener et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K. Ghosh et al.
BLOOD (2009)
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Aldo M. Roccaro et al.
BLOOD (2009)
Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells
Daniela Bonofiglio et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Lessons Learned from the Study of JunB: New Insights for Normal and Leukemia Stem Cell Biology
Monica L. Guzman et al.
CANCER CELL (2009)
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited
Sonja Loges et al.
CANCER CELL (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Cancer and the tumor microenvironment: a review of an essential relationship
Flaubert Mbeunkui et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival
Tatiana M. Garcia-Bates et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
PPARγ-independent antitumor effects of thiazolidinediones
Shuo Wei et al.
CANCER LETTERS (2009)
Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade
Francesca Spinella et al.
CANCER RESEARCH (2009)
Consistent Deregulation of Gene Expression between Human and Murine MLL Rearrangement Leukemias
Zejuan Li et al.
CANCER RESEARCH (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Targeting the tumour stroma to increase efficacy of chemo- and radiotherapy
Gretel Chometon et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Tumor Endothelial Cells Join the Resistance
Andrew C. Dudley et al.
CLINICAL CANCER RESEARCH (2009)
PPARγ and its ligands: therapeutic implications in cardiovascular disease
Luis Villacorta et al.
CLINICAL SCIENCE (2009)
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Salvatore Ulisse et al.
CURRENT CANCER DRUG TARGETS (2009)
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration
Thomas A. Ciulla et al.
CURRENT OPINION IN OPHTHALMOLOGY (2009)
Targeting the Tumor Stroma in Cancer Therapy
Kevin Anton et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2009)
Bortezomib A Review of its Use in Patients with Multiple Myeloma
Monique P. Curran et al.
DRUGS (2009)
How safe is the use of thiazolidinediones in clinical practice?
C. V. Rizos et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Targeting STAT3 in cancer: how successful are we?
Pedbin Yue et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
VEGF inhibitors for the treatment of neovascular age-related macular degeneration
Mark Rami Barakat et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
A role of miR-27 in the regulation of adipogenesis
Qun Lin et al.
FEBS JOURNAL (2009)
Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation
Juling Ji et al.
FEBS LETTERS (2009)
The major inflammatory mediator interleukin-6 and obesity
Katalin Eder et al.
INFLAMMATION RESEARCH (2009)
Revisiting the seed and soil in cancer metastasis
Martin Mendoza et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18β-olean-1,12-dien-30-oate in colon cancer cells
Sudhakar Chintharlapalli et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells
Abha Sahni et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
RADIATION THERAPY ONCOLOGY GROUP TRANSLATIONAL RESEARCH PROGRAM STEM CELL SYMPOSIUM: INCORPORATING STEM CELL HYPOTHESES INTO CLINICAL TRIALS
Wendy A. Woodward et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
MicroRNAs as a therapeutic target for cardiovascular diseases
Paras Kumar Mishra et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Cancer Stem Cells: A Guide for Skeptics
Michael H. Tomasson
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
Daniel H. Solomon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
Raffaele Baffa et al.
JOURNAL OF PATHOLOGY (2009)
Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity
Nathan T. Ihle et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?
D. Ribatti
LEUKEMIA (2009)
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
S. Giralt et al.
LEUKEMIA (2009)
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma
Jia Ruan et al.
LEUKEMIA & LYMPHOMA (2009)
MicroRNAs in the ontogeny of leukemias and lymphomas
Muller Fabbri et al.
LEUKEMIA & LYMPHOMA (2009)
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T. Stopeck et al.
LEUKEMIA & LYMPHOMA (2009)
Endogenous inhibitors of angiogenesis A historical review
Domenico Ribatti
LEUKEMIA RESEARCH (2009)
Lymphangiogenesis in haematological malignancies
Domenico Ribatti
LEUKEMIA RESEARCH (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Biogenesis of small RNAs in animals
V. Narry Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Peroxisome proliferator-activated receptors and angiogenesis
F. Biscetti et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells
A. Papi et al.
ONCOLOGY REPORTS (2009)
The tumour microenvironment: a novel target for cancer therapy
E. Hanna et al.
ORAL DISEASES (2009)
The Promoter of the pri-miR-375 Gene Directs Expression Selectively to the Endocrine Pancreas
Tali Avnit-Sagi et al.
PLOS ONE (2009)
The Increasing Complexity of the Cancer Stem Cell Paradigm
Jeffrey M. Rosen et al.
SCIENCE (2009)
Friend or foe? Role of peroxisome proliferator-activated receptor-γ in human bladder cancer
Teruo Inamoto et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor γ involves angiogenesis inhibition
Yu-Wei Dong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Topography of Extracellular Matrix Mediates Vascular Morphogenesis and Migration Speeds in Angiogenesis
Amy L. Bauer et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
David N. Juurlink et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Treatment of Multiple Myeloma: A Comprehensive Review
Robert A. Kyle et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Suppression of Retinal Peroxisome Proliferator-Activated Receptor γ in Experimental Diabetes and Oxygen-Induced Retinopathy: Role of NADPH Oxidase
Amany Tawfik et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype
Erin Connolly et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Capillary sprout endothelial cells exhibit a CD36low phenotype
Christopher R. Anderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
Olga Gealekman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
Ahmad Aljada et al.
ANGIOGENESIS (2008)
Vascular determinants of cancer stem cell dormancy - do age and coagulation system play a role?
Janusz Rak et al.
APMIS (2008)
Rosiglitazone and delayed onset of proliferative diabetic retinopathy
Lucy Q. Shen et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
The role of 15-deoxy-Δ12,14-prostaglandin J2, an endogenous ligand of peroxisome proliferator-activated receptor γ, in tumor angiogenesis
Eun-Hee Kim et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice
Po-Hsun Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
PPARγ agonists inhibit growth and expansion of CD133+brain tumour stem cells
W. Chearwae et al.
BRITISH JOURNAL OF CANCER (2008)
Antiangiogenesis in haematological malignancies
William W. Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Cancer stem cells: markers or biomarkers?
Wendy A. Woodward et al.
CANCER AND METASTASIS REVIEWS (2008)
Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies
Axel Grothey et al.
CANCER JOURNAL (2008)
Is tumor growth sustained by rare cancer stem cells or dominant clones?
Jerry M. Adams et al.
CANCER RESEARCH (2008)
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells
Thales Papagiannakopoulos et al.
CANCER RESEARCH (2008)
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
Shu Takakura et al.
CANCER SCIENCE (2008)
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
Victor W. M. van Hinsbergh et al.
CARDIOVASCULAR RESEARCH (2008)
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Carmen Urbich et al.
CARDIOVASCULAR RESEARCH (2008)
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells
Alexander Marson et al.
CELL (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
The I kappa B kinase - a bridge between inflammation and cancer
Michael Karin
CELL RESEARCH (2008)
Peroxisome proliferator-activated receptor-γ-mediated effects in the vasculature
Sheng Zhong Duan et al.
CIRCULATION RESEARCH (2008)
Cardiac toxicity: old and new issues in anti-cancer drugs
Maria Sereno et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Peroxisome Proliferator-Activated Receptor γ Overexpression Suppresses Growth and Induces Apoptosis in Human Multiple Myeloma Cells
Tatiana M. Garcia-Bates et al.
CLINICAL CANCER RESEARCH (2008)
Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems
Brian R. J. Healey Bird et al.
CLINICAL CANCER RESEARCH (2008)
Pathways Mediating Resistance to Vascular Endothelial Growth Factor - Targeted Therapy
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2008)
Reassessing the cardiovascular risks and benefits of thiazolidinediones
Andrew Zinn et al.
CLINICAL CARDIOLOGY (2008)
PPARγ Agonists and Coronary Atherosclerosis
Melanie S. Sulistio et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer
K. Towns et al.
CURRENT ONCOLOGY (2008)
NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents
M. Teresa Cibeira et al.
CYTOKINE (2008)
Hungry for blood vessels: Linking metabolism and angiogenesis
Peter Fraisl et al.
DEVELOPMENTAL CELL (2008)
Selective activation of peroxisome proliferator-activated receptor (PPAR)α and PPARγ induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism
Federico Biscetti et al.
DIABETES (2008)
Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone
N. L. Julie et al.
DIABETOLOGIA (2008)
The tumor microenvironment and its contribution to tumor evolution toward metastasis
Girieca Lorusso et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Stromal myofibroblasts are drivers of invasive cancer growth
Olivier De Wever et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin
Domenica Mangieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Peroxisome proliferator-activated receptor γ and lung cancer biology
Jesse Roman
JOURNAL OF INVESTIGATIVE MEDICINE (2008)
PPAR-gamma and aging: one link through klotho?
Ruihua Zhang et al.
KIDNEY INTERNATIONAL (2008)
Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway
Yingxia Bao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Jie Ma et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Novel anti-myeloma agents and angiogenesis
Konstantinos Anargyrou et al.
LEUKEMIA & LYMPHOMA (2008)
MicroRNAs regulate ocular neovascularization
Jikui Shen et al.
MOLECULAR THERAPY (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
Thiazolidinediones may be effective in the prevention of stent thrombosis with DES
Zheng Cao et al.
MEDICAL HYPOTHESES (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Zejuan Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
Dipak Panigrahy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis
Yajaira Suarez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
The wolf in sheep's clothing: the role of interieukin-6 in immunity, inflammation and cancer
Willscott E. Naugler et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Targeting microRNA expression to regulate angiogenesis
Angelika Kuehbacher et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells
Yan-Ming Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer
Costas Giaginis et al.
PPAR RESEARCH (2008)
Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
TatianaM. Garcia-Bates et al.
PPAR RESEARCH (2008)
Clinical Use of PPAR gamma Ligands in Cancer
Jennifer L. Hatton et al.
PPAR RESEARCH (2008)
The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects
S. L. Spinelli et al.
PPAR RESEARCH (2008)
Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
Dingzhi Wang et al.
PPAR RESEARCH (2008)
Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types
Jack D. Burton et al.
PPAR RESEARCH (2008)
PPAR gamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents
Ioannis Sainis et al.
PPAR RESEARCH (2008)
Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPAR gamma Dependent and Independent Mechanisms
Qing He et al.
PPAR RESEARCH (2008)
A Role for PPAR gamma in the Regulation of Cytokines in Immune Cells and Cancer
Xiao Yi Yang et al.
PPAR RESEARCH (2008)
PPARs Mediate Lipid Signaling in Inflammation and Cancer
Liliane Michalik et al.
PPAR RESEARCH (2008)
PPAR gamma Agonists: Potential as Therapeutics for Neovascular Retinopathies
Harrihar A. Pershadsingh et al.
PPAR RESEARCH (2008)
PPAR gamma and Agonists against Cancer: Rational Design of Complementation Treatments
Dorina Veliceasa et al.
PPAR RESEARCH (2008)
The Role of PPARs in Cancer
Keisuke Tachibana et al.
PPAR RESEARCH (2008)
Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
Meletios A. Dimopoulos et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
Update on the use of fibrates: focus on bezafibrate
Ilan Goldenberg et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5
Yun Chen et al.
BLOOD (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Jeanine M. Roodhart et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Immune cells as mediators of solid tumor metastasis
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2008)
Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARγ cross talk with NF-κB and C/EBPβ
Li Hua Wang et al.
BLOOD (2007)
PPARγ-active triterpenoid CDDO enhances ATRA-induced differentiation in APL
Yoko Tabe et al.
CANCER BIOLOGY & THERAPY (2007)
Body mass index and risk of multiple myeloma: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
VEGF signaling inhibitors: More pro-apoptotic than anti-angiogenic
Richard J. Epstein
CANCER AND METASTASIS REVIEWS (2007)
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer-binding protein alpha
Steffen Koschmieder et al.
BLOOD (2007)
Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma
Scot Ebbinghaus et al.
CLINICAL CANCER RESEARCH (2007)
Genomic analysis of human microRNA transcripts
Harpreet Kaur Saini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Playing only one instrument may be not enough: limitations and future of the antianglogenic treatment of cancer
Ana R. Quesada et al.
BIOESSAYS (2007)
Modulation of endothelial responses by the stromal microenvironment: effects on leucocyte recruitment
H. M. McGettrick et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation
Hoon Han et al.
APOPTOSIS (2007)
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells
Valerie B. Sampson et al.
CANCER RESEARCH (2007)
LIF- and IL-6-Induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation
Norihiko Ohbayashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Comorbidity in older surgical cancer patients: Influence on patient care and outcome
Maryska L. G. Janssen-Heijnen et al.
EUROPEAN JOURNAL OF CANCER (2007)
Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Autocrine VEGF signaling is required for vascular homeostasis
Sunyoung Lee et al.
CELL (2007)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
The non-genomic crosstalk between PPAR-γ ligands and ERK1/2 in cancer cell lines
Efstathia Papageorgiou et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?
Roger S. McIntyre et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Molecular basis of selective PPARγ modulation for the treatment of type 2 diabetes
Laurent Gelman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Intronic microRNA precursors that bypass Drosha processing
J. Graham Ruby et al.
NATURE (2007)
PPAR agonists and the metabolic syndrome
Bart Staels
THERAPIE (2007)
Effect of overexpression of pparγ on the healing process of corneal alkali burn in mice
Shizuya Saika et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Peroxisome proliferator-activated receptor α regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation
Yatrik A. Shah et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma
Svetomir N. Markovic et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
MicroRNAs and haematology: small molecules, big function
Charles H. Lawrie
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1
Tae-Hee Lee et al.
PLOS MEDICINE (2007)
Elevated vascular endothelial growth factor pretreatment levels are correlated with the tumor burden in Hodgkin lymphoma and continue to be elevated in prolonged complete remission
Antonio Rueda et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling
Xiaoyang Ling et al.
CANCER RESEARCH (2007)
The PPAR-γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells
Christoph Gensch et al.
ATHEROSCLEROSIS (2007)
Angiogenesis and antiangiogenic therapy in hematologic malignancies
Xunwei Dong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells
Yajaira Suarez et al.
CIRCULATION RESEARCH (2007)
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions
Kenneth C. Anderson
EXPERIMENTAL HEMATOLOGY (2007)
The leukemic stem cell
Craig T. Jordan
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-γ agonists induced apoptosis in human monocyte leukemia cells in vitro
Jia-Jun Liu et al.
ANNALS OF HEMATOLOGY (2007)
The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore
Paul S. Brookes et al.
CANCER RESEARCH (2007)
Activation of peroxisome proliferator-activated receptor γ contributes to the survival of T lymphoma cells by affecting cellular metabolism
Chunyan Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Review:: Peroxisome proliferator-activated receptor γ and adipose tissue -: Understanding obesity-related changes in regulation of lipid and glucose metabolism
Arya M. Sharma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies
Torsten Kessler et al.
CURRENT DRUG TARGETS (2007)
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Satoshi Hirakawa et al.
BLOOD (2007)
Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ
Serena Ghisletti et al.
MOLECULAR CELL (2007)
MicroRNAs in tumorigenesis - A primer
Wenyong Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Activation of PPAR beta/delta induces endothelial cell proliferation and angiogenesis
Laura Piqueras et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
Sarah X. Zhang et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2007)
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Mollie A. Jay et al.
CURRENT DIABETES REVIEWS (2007)
The potential of peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands in the treatment of hematological malignancies
C. Ulivieri et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
ShouWei Han et al.
ANTI-CANCER DRUGS (2007)
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage
Jae-Hyuk Yi et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Protection of RPE cells from oxidative injury by 15-deoxy-Δ12,14-prostaglandin J2 by augmenting GSH and activating MAPK
Suofu Qin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
Deregulated NF-κB activity in haematological malignancies
Aurore Keutgens et al.
BIOCHEMICAL PHARMACOLOGY (2006)
The peroxisome proliferator-activated receptor γ (PPARγ) ligands 15-deoxy-Δ12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARγ-independent mechanisms
Denise M. Ray et al.
JOURNAL OF IMMUNOLOGY (2006)
Dual PPAR α/γ ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines
Chuanbing Zang et al.
CELL CYCLE (2006)
Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes
Steven E. Feldon et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism
Francois Willermain et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2006)
Metabolic syndrome and diabetic atherothrombosis: Implications in vascular complications
P. Meerarani et al.
CURRENT MOLECULAR MEDICINE (2006)
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma
Jan Eucker et al.
ANTI-CANCER DRUGS (2006)
The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells
Karen Liby et al.
CLINICAL CANCER RESEARCH (2006)
15-Deoxy-Δ 12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis
Susumu Nakata et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia
Kon Chu et al.
BRAIN RESEARCH (2006)
Targeting NF-κB in hematologic malignancies
T Braun et al.
CELL DEATH AND DIFFERENTIATION (2006)
Anthropometry and multiple myeloma
C Bosetti et al.
EPIDEMIOLOGY (2006)
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD 18
HY Liu et al.
BLOOD (2006)
Normal stem cells and cancer stem cells: The niche matters
Linheng Li et al.
CANCER RESEARCH (2006)
Peroxisome proliferator-activated receptor γ ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells
E Yasugi et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2006)
Peroxisome proliferator-activated receptor γ in malignant diseases
TT Wang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype
JA Nagy et al.
EXPERIMENTAL CELL RESEARCH (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Peroxisome proliferator-activated receptor-γ activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors
U Campia et al.
CIRCULATION (2006)
Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL)
T Mainou-Fowler et al.
LEUKEMIA & LYMPHOMA (2006)
Angiostatic effect of penetrating ocular injury: Role of pigment epithelium-derived factor
JS Penn et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Role of angiogenesis in chronic lymphocytic leukemia
Tomislav Letilovic et al.
CANCER (2006)
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells
AM Roccaro et al.
CANCER RESEARCH (2006)
Platelets as a novel target for PPAR gamma ligands - Implications for inflammation, diabetes, and cardiovascular disease
Denise M. Ray et al.
BIODRUGS (2006)
Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18)
M. Takenokuchi et al.
ACTA HAEMATOLOGICA (2006)
Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic
Girolamo Ranieri et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukemia
P Liu et al.
LEUKEMIA & LYMPHOMA (2005)
Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop
JM Vieira et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells
F Pistrosch et al.
ATHEROSCLEROSIS (2005)
The role of IL-6 and STAT3 in inflammation and cancer
DR Hodge et al.
EUROPEAN JOURNAL OF CANCER (2005)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells
JJ Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Anthropometric characteristics and risk of multiple myeloma
CK Blair et al.
EPIDEMIOLOGY (2005)
Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARγ mRNA expression and modulates SR-BI gene expression in murine macrophages
T Westendorf et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Q Xu et al.
ONCOGENE (2005)
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma
A Vacca et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Therapeutic roles of peroxisome proliferator-activated receptor agonists
B Staels et al.
DIABETES (2005)
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
R Hoekstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PPARγ as a therapeutic target for tumor angiogenesis and metastasis
D Panigrahy et al.
CANCER BIOLOGY & THERAPY (2005)
Troglitazone reverses the inhibition of nitric oxide production by high glucose in cultured bovine retinal pericytes
J Kim et al.
EXPERIMENTAL EYE RESEARCH (2005)
CLL, but not normal, B cells are dependent on autocrine VEGF and α4β1 integrin for chemokine-induced motility on and through endothelium
KJ Till et al.
BLOOD (2005)
A microRNA polycistron as a potential human oncogene
L He et al.
NATURE (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities
F Haviv et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A novel ring-substituted diindolylmethane, 1,1-bis[3′-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia
R Contractor et al.
CANCER RESEARCH (2005)
Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-γ ligand
MA Sarayba et al.
EXPERIMENTAL EYE RESEARCH (2005)
Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro
JJ Liu et al.
ANNALS OF ONCOLOGY (2005)
PPAR-γ activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer
VG Keshamouni et al.
NEOPLASIA (2005)
Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARγ-independent mechanism
M Artwohl et al.
DIABETOLOGIA (2005)
Nitrolinoleic acid:: An endogenous peroxisome proliferator-activated receptor γ ligand
FJ Schopfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
15-Deoxy-Δ12,14-prostaglandin J2 induces apoptosis in human malignant B cells:: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins
R Piva et al.
BLOOD (2005)
Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPAR alpha, PPAR gamma, and PPAR delta
Joseph L. Evans et al.
CURRENT DIABETES REVIEWS (2005)
New indications for established drugs: Combined tumor-stroma-targeted cancer therapy with PPAR gamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy
C Hafner et al.
CURRENT CANCER DRUG TARGETS (2005)
CDDO induces apoptosis via the intrinsic pathway in lymphoid cells
S Inoue et al.
LEUKEMIA (2004)
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance
D Chauhan et al.
BLOOD (2004)
Peroxisome proliferator-activated receptor γ ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia
CB Zang et al.
LEUKEMIA RESEARCH (2004)
Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage - A new paradigm in glitazone pleiotropy
CH Wang et al.
CIRCULATION (2004)
Transcriptional inactivation of STAT3 by PPARγ suppresses IL-6-responsive multiple myeloma cells
LH Wang et al.
IMMUNITY (2004)
Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-γ ligands -: Putative contribution of Rho GTPases in statin-induced CD36 expression
N Ruiz-Velasco et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Nuclear export of microRNA precursors
E Lund et al.
SCIENCE (2004)
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2
HF Zhang et al.
LEUKEMIA & LYMPHOMA (2004)
Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes
F Akbiyik et al.
BLOOD (2004)
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in mycosis fungoides/Sezary syndrome cells
CL Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy
D Pasquali et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
G Meister et al.
MOLECULAR CELL (2004)
Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role
T Sharma et al.
EYE (2004)
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes - Therapeutic strategy for herpetic stromal keratitis
B Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
M Chatterjee et al.
BLOOD (2004)
Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases
H Takano et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo
ES Wang et al.
BLOOD (2004)
Human multiple myeloma cells express peroxisome proliferator-activated receptor γ and undergo apoptosis upon exposure to PPARγ ligands
DM Ray et al.
CLINICAL IMMUNOLOGY (2004)
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia
M Konopleva et al.
CANCER RESEARCH (2004)
Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): Therapy induced changes and effects on survival
I Kuzu et al.
LEUKEMIA & LYMPHOMA (2004)
Ligands of peroxisome proliferator-activated receptor γ induce apoptosis in multiple myeloma
J Eucker et al.
ANTI-CANCER DRUGS (2004)
The obesity epidemic in the United States
AC Morrill et al.
JOURNAL OF PUBLIC HEALTH POLICY (2004)
Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways
SCR Santos et al.
BLOOD (2004)
Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy
MR Smith et al.
CANCER (2004)
Bifunctional properties of peroxisome proliferator-activated receptor γ 1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3
Y Sassa et al.
DIABETES (2004)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma
T Hideshima et al.
ONCOGENE (2003)
The nuclear RNase III Drosha initiates microRNA processing
Y Lee et al.
NATURE (2003)
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D
BK McColl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD36: A critical anti-angiogenic receptor
R Simantov et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Role of PPAR-γ ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells
P Aoun et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
HJ Burstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Differential recruitment of the coactivator proteins CREB-binding protein and steroid receptor coactivator-1 to peroxisome proliferator-activated receptor gamma/9-cis-retinoic acid receptor heterodimers by ligands present in oxidized low-density lipoprotein
J Wigren et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Modulation of PPARγ activity with pharmaceutical agents:: Treatment of insulin resistance and atherosclerosis
MH Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Pleiotropic vascular effects of PPARγ ligands
AR Collins
DRUG NEWS & PERSPECTIVES (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Novel biologically based therapies for Waldenstrom's macroglobulinemia
CS Mitsiades et al.
SEMINARS IN ONCOLOGY (2003)
Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro
GPV Amerongen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
DY Wei et al.
ONCOGENE (2003)
Identification of an intracellular receptor for lysophosphatidic acid (LPA):: LPA is a transcellular PPARγ agonist
TM McIntyre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ocular involvement in leukemia - A study of 288 cases
SC Reddy et al.
OPHTHALMOLOGICA (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The triterpenoid CDDO induces apoptosis in refractory CLL B cells
IM Pedersen et al.
BLOOD (2002)
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
D Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36
M Febbraio et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
A microRNA in a multiple-turnover RNAi enzyme complex
G Hutvágner et al.
SCIENCE (2002)
A phase II study of troglitazone, an activator of the PPARγ receptor, in patients with chemotherapy-resistant metastatic colorectal cancer
MH Kulke et al.
CANCER JOURNAL (2002)
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
HP Gerber et al.
NATURE (2002)
Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor α and γ ligands
O Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics
FK Reiher et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Human B lymphocytes and B lymphomas express PPAR-γ and are killed by PPAR-γ agonists
J Padilla et al.
CLINICAL IMMUNOLOGY (2002)
A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies
SV Rajkumar et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2002)
Prostaglandin D-2, its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells
SG Harris et al.
IMMUNOLOGY (2002)
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia
M Konopleva et al.
BLOOD (2002)
Peroxisome proliferator-activated receptor gamma (PPAR gamma) and its ligands: A review
KL Houseknecht et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2002)
HIF-1 and tumor progression: pathophysiology and therapeutics
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2002)
Ocular manifestations of leukemia - Leukemic infiltration versus infectious process
KB Gordon et al.
OPHTHALMOLOGY (2001)
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors
R Masood et al.
BLOOD (2001)
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice
L Michalik et al.
JOURNAL OF CELL BIOLOGY (2001)
PPARs in inflammation, atherosclerosis and thrombosis
H Duez et al.
JOURNAL OF CARDIOVASCULAR RISK (2001)
Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN
L Patel et al.
CURRENT BIOLOGY (2001)
Response of experimental retinal neovascularization to thiazolidinediones
T Murata et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
被撤回的出版物: Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2 -: Evidence for involvement of activator protein-1 and CREB-binding protein/p300 (Retracted article. See vol. 295, pg. 291, 2020)
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
HIF-1 and mechanisms of hypoxia sensing
GL Semenza
CURRENT OPINION IN CELL BIOLOGY (2001)
Advances in disease biology: Therapeutic implications
KC Anderson
SEMINARS IN HEMATOLOGY (2001)
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2) - A reassessment using novel receptor-specific vascular endothelial growth factor mutants
H Gille et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The pleiotropic functions of peroxisome proliferator-activated receptor gamma
MB Debril et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Peroxisome proliferator activator receptor-γ agonists and 15-deoxy-Δ12,14-PGJ2 induce apoptosis in normal and malignant B-lineage cells
J Padilla et al.
JOURNAL OF IMMUNOLOGY (2000)
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes
U Kintscher et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
S Dias et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells
K Yamakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562
N Hirase et al.
LEUKEMIA RESEARCH (2000)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
